Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Infectious Diseases and Therapy|January 25, 2020
Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient SettingRavina Kullar, Laura A Puzniak, Jason P Swindle, et al.
Diagnostic Microbiology and Infectious Disease|December 24, 2013
Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysisLaura A Puzniak, Blair Capitano, Pinaki Biswas, et al.
Plos One|July 22, 2015
Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP)Andrew F Shorr, Laura A Puzniak, Pinaki Biswas, et al.
Infectious Diseases and Therapy|September 30, 2020
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP TrialThomas Lodise, Joe Yang, Laura A Puzniak, et al.
Infection Control and Hospital Epidemiology|March 24, 2022
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, et al.
Surgical Infections|July 18, 2013
The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureusTherèse M Duane, Blair Capitano, Laura A Puzniak, et al.
Pharmacotherapy|January 15, 2014
Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumoniaAisling R Caffrey, Haley J Morrill, Laura A Puzniak, et al.
Surgical Infections|May 10, 2012
Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular diseaseTherèse M Duane, John A Weigelt, Laura A Puzniak, et al.
Diagnostic Microbiology and Infectious Disease|April 15, 2014
Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trialsLaura A Puzniak, Alvaro Quintana, Michele Wible, et al.
Clinical Therapeutics|September 10, 2013
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusLaura A Puzniak, Lee E Morrow, David B Huang, et al.
Pageof 4